Scope Fluidics S.A. (WSE:SCP)
Poland · Delayed Price · Currency is PLN 136.40
-0.20 (-0.15%)
Aug 14, 2026, 5:00 PM CET
Scope Fluidics Revenue
Scope Fluidics had revenue of 27.00K PLN in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 698.00K, up 528.83% year-over-year. In the year 2024, Scope Fluidics had annual revenue of 131.00K, down -74.61%.
Revenue (ttm)
698.00K
Revenue Growth
+528.83%
P/S Ratio
4,155.31
Revenue / Employee
n/a
Employees
157
Market Cap
432.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.00K | -385.00K | -74.61% |
| Dec 31, 2023 | 516.00K | 112.00K | 27.72% |
| Dec 31, 2022 | 404.00K | - | - |
| Dec 31, 2021 | 0 | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 1.80K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 183.23K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 932.97M |
| Centrum Medyczne ENEL-MED | 885.29M |
| Voxel | 583.14M |
| Mercator Medical | 572.42M |
| Selvita | 359.37M |
| BIOTON | 266.02M |